［1］Algazi AP，Soon CW，Ai D.Treatment of cutaneous melanoma：Current approaches and future prospects［J］.Cancer Management and Research，2010，2(2)：197-211.
［2］Jemal A，Siegel R，Ward E，et al.Cancer Statistics，2008［J］.Ca A Cancer Journal for Clinicians，2008，58(2)：71-96.
［3］Hassan M，Watari H，AbuAlmaaty A，et al.Apoptosis and molecular targeting therapy in cancer［J］.BioMed Research International，2014，2014(2)：1-23.
［4］American Cancer Society.2014 Cancer Facts and Figures［J/OL］.Atlanta，GA：American Cancer Society，2014.http：//www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.
［5］Linos E，Swetter SM，Cockburn MG，et al.Increasing burden of melanoma in the United States［J］.J Invest Dermatol，2009，129(7)：1666-1674.
［6］Morton DL，Thompson JF，Cochran AJ，et al.Sentinel-node biopsy or nodal observation in melanoma［J］.N Engl J Me，2006，355(13)：1307-1317.
［7］McMasters KM，Wong SL，Edwards MJ，et al.Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma［J］.Surgery，2001，130(2)：151-156.
［8］Balch CM，Soong SJ，Smith T，et al.Long-term results of a prospective surgical trial comparing 2 cm vs.4 cm excision margins for 740 patients with 1~4mm melanomas［J］.Ann Surg Oncol，2001，8(2)：101-108.
［9］Cohn-Cedermark G，Rutqvist LE，Andersson R，et al.Long term results of a randomized study by the Swedish Melanoma Study Group on 2cm versus 5cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8~2.0mm［J］.Cancer，2000，89(7)：1495-1501.
［10］Overgaard J.The role of radiotherapy in recurrent and metastatic malignant melanoma：A clinical radiobiological study［J］.Int J Radiat Oncol Biol Phys，1986，12(6)：867-872.
［11］Min L，Hodi FS.Anti-PD1 following ipilimumab for mucosal melanoma：Durable tumor response associated with severe hypothyroidism and rhabdomyolysis［J］.Cancer Immunology Research，2014，2(1)：15-18.
［12］Kirkwood JM，Ibrahim JG，Sondak VK，et al.High-and low dose interferon alfa-2b in high-risk melanoma：First analysis of intergroup trial E1690/S9111/C9190［J］.J Clin Oncol，2000，18(12)：2444-2458.
［13］Robert C，Long GV，Brady B，et al.Nivolumab in previously untreated melanoma without BRAF mutation［J］.N Engl J Med，2015，372(4)：320-330.
［14］Yamakawa N，Takahashi A，Mori E，et al.High LET radiation enhances apoptosis in mutated p53 cancer cells through Caspase-9 activation［J］.Cancer science，2008，99(7)：1455-1460.
［15］Dudley T.Mechanisms for the biological effectiveness of high-let radiation［J］.J Radiat Res，1999，40(12)：1-13.
［16］Bing Wang KT，Guillaume Vares，Yi Shang，et al.X-ray-induced radioresistance against high-LET radiations from accelerated heavy ions in mice［J］.Radiation Research，2010，174(4)：532-536.
［17］Hamada N，Hara T，Omura-Minamisawa M，et al.Energetic heavy ions overcome tumor radioresistance caused by overexpression of Bcl-2［J］.Radiotherapy and Oncology，2008，89(2)：231-236.
［18］Le ZY，Liu Y.Research progress in oncology radiobiology of heavy ion［J］.Chin J Radiation Oncology，2015，24(5)：600-604.［乐紫妤，刘勇.重离子肿瘤放射生物学的研究进展［J］.中华放射肿瘤学杂志，2015，24(5)：600-604.］
［19］Di CX，Yang LN，Zhang H，et al.Effects of carbon-ion beam or X-ray irradiation on anti-apoptosis DeltaNp73 expression in HeLa cells［J］.Gene，2013，515(1)：208-213.
［20］Thomas Friedrich，Uwe Scholz，Thilo Elsasser.Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation［J］.J Radiat Res，2013，54(3)：494-514.
［21］Gong L，Jin X，Li Q，et al.Heavy ion beams induce survivin expression in human hepatoma smmc-7721 cells more effectively than x-rays［J］.Acta Biochimica et Biop hysica Sinica，2007，39(8)：575-582.
［22］Silvia Molinelli，Giuseppe Magro，Andrea Mairani，et al.Dose prescription in carbon ion radiotherapy：How to compare two different RBE-weighted dose calculation systems［J］.Radiotherapy and Oncology，2016，120(2)：307-312.
［23］Li FM，Nie Q，Xia TY.Research progress in carbon ion beam-hign linear energy transfer radiotherapy for cancer［J］.Chin J Clin Oncol and Rehabilitation，2008，17(6)：483-488.［李方明，聂青，夏廷毅.重粒子束高LET射线肿瘤放疗研究进展［J］.中国肿瘤临床与康复，2008，17(6)：483-488.］
［24］Schmid TE，Dollinger G，Beisker W，et al.Differences in the kinetics of gamma-H2AX fluorescence decay after exposure to low and high LET radiation［J］.International J Radiation Biology，2010，86(6)：682-691.
［25］George Hwvwyfk.High-and low-LET induced chromosome damage in human lymphocytes：a time-course of aberrations in metaphase and interphase［J］.International J Radiation Biology，2001，77(2)：175-183.
［26］Shinoto M，Yamada S，Terashima K，et al.Carbon ion radiation therapy with concurrent Gemcitabine for patients with locally advanced pancreatic cancer［J］.Int J Radiation Oncol Biol Phys，2016，95(1)：498-504.
［27］Wu MY，Qiang YZ，Zhang XG.Ion irradiation and the biological effect of immune system［J］.Foreign Med Sci·Sec Radiat Med Nucl Med，2004，28(6)：274-277.［吴明媛，强亦忠，张学光.电离辐射与免疫系统的生物学效应［J］.国外医学放射医学核医学分册，2004，28(6)：274-277.］
［28］Rao NG，Yu HH，Trotti A，et al.The role of radiation therapy in the management of cutaneous melanoma［J］.Surg Oncol Clin N Am，2011，20(1)：115-131.
［29］Andrea Forschner，Vanessa Heinrich，Annette Pflugfelder，et al.The role of radiotherapy in the overall treatment of melanoma［J］.Clinics in Dermatology，2013，31(3)：282-289.
［30］T Kamada，H Tsujii，EA Blakely，et al.Policy Review Carbon ion radiotherapy in Japan：An assessment of 20 years of clinical experience［J］.Article in the Lancet Oncology，2015，16(2)：93-100.
［31］Kumiko Karasawa，Masaru Wakatsuki，Shingo Kato，et al.Clinical trial of carbon ion radiotherapy for gynecological melanoma［J］.J Radiation Research，2014，55(2)：343-350.
［32］Keiichi Jingu，Riwa Kishimoto，Jun-Etsu Mizoe，et al.Malignant mucosal melanoma treated with carbon ion radiotherapy with concurrent chemotherapy：Prognostic value of pretreatment apparent diffusion coefficient(ADC)［J］.Radiotherapy and Oncology，2011，98(1)：68-73.
［33］Demizu Y，Fujii O，Terashima K，et al.Particle therapy for mucosal melanoma of the head and neck.A single-institution retrospective comparison of proton and carbon ion therapy［J］.Strahlenther Onko，2014，190(2)：186-191.
［34］Cai HY，Wang XH，Gao LY，et al.Short-term clinical outcome of carbon ion radiotherapy for cutaneous malignant melanoma［J］.Chin J Radiation Oncol，2010，19(3)：250-252.［蔡宏懿，王小虎，高力英，等.碳离子束治疗皮肤恶性黑色素瘤的近期疗效［J］.中华放射肿瘤学杂志，2010，19(3)：250-252.］
［35］Wei SH，Liu Q，Zhang H，et al.Recrudescent malignant melanoma cured by 12C6+ heavy ion beam radiotherapy［J］.Medical J National Defending Forces in Northwest China，2011，32(4)：247-249.［魏世华，刘倩，张红，等.重离子束治疗恶性黑色素瘤临床研究及疗效观察［J］.西北国防医学杂志，2011，32(4)：247-249.］
［36］Li S，Zhang H，Wei SH，et al.Clinical trials of carbon ion beam therapy on superficial layer tumor China［J］.Chin J Radiation Oncol，2008，17(6)：263-264.［李莎，张红，魏世华，等.碳离子束治疗浅层肿瘤的临床试验结果［J］.中华放射肿瘤学杂志，2008，17(6)：263-264.］